Volume 120, Issue 7, Pages (June 2001)

Slides:

Advertisements

Similar presentations

Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.

Advertisements

Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer

Risk of recurrence of Barrett’s esophagus after successful endoscopic therapy Rajesh Krishnamoorthi, MD, Siddharth Singh, MD, Karthik Ragunathan, MD,

Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis Marjolein Sikkema, Pieter.

Esophageal Adenocarcinoma

Volume 152, Issue 1, Pages (January 2017)

Fig. 1 Flow diagram of patient selection and study design.

Volume 120, Issue 7, Pages (June 2001)

Volume 119, Issue 4, Pages (October 2000)

The Seattle Protocol Does Not More Reliably Predict the Detection of Cancer at the Time of Esophagectomy Than a Less Intensive Surveillance Protocol

How to Manage a Barrett's Esophagus Patient With Low-Grade Dysplasia

Frozen Section Analysis of Esophageal Endoscopic Mucosal Resection Specimens in the Real-Time Management of Barrett’s Esophagus Ganapathy A. Prasad,

Volume 122, Issue 3, Pages (March 2002)

Volume 115, Issue 6, Pages (December 1998)

Persistence of Human Papillomavirus, Overexpression of p53, and Outcomes of Patients After Endoscopic Ablation of Barrett's Esophagus Shanmugarajah Rajendra,

First successful treatment of a primary high-grade gastric MALT lymphoma by eradication therapy for Helicobacter pylori Stephan Timm, Marco Sailer, Karl–hermann.

Diagnosis of irritable bowel syndrome

Lawrence K. Gates, Dawn V. Holladay Gastroenterology

Volume 137, Issue 3, Pages (September 2009)

Volume 119, Issue 3, Pages (September 2000)

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? William E. Whitehead, Olafur.

Volume 120, Issue 7, Pages (June 2001)

Volume 117, Issue 5, Pages (November 1999)

Volume 123, Issue 1, Pages (July 2002)

Volume 122, Issue 7, Pages (June 2002)

Volume 152, Issue 5, Pages (April 2017)

Volume 149, Issue 3, Pages e3 (September 2015)

Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma Jörg Zehetner, MD, Steven R. DeMeester,

Molecular Imaging in Gastrointestinal Endoscopy

Volume 119, Issue 3, Pages (September 2000)

Volume 122, Issue 7, Pages (June 2002)

Volume 142, Issue 2, Pages (February 2012)

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families Paul D.P. Pharoah,

Volume 119, Issue 4, Pages (October 2000)

Patients With Barrett’s Esophagus and Persistent Low-grade Dysplasia Have an Increased Risk for High-grade Dysplasia and Cancer Christine Kestens, G.

Antje Timmer*, Lloyd R. Sutherland*,‡, Francois Martin§

A Cost-Utility Analysis of Ablative Therapy for Barrett's Esophagus

Volume 122, Issue 1, Pages (January 2002)

Distribution of Body Fat and Its Influence on Esophageal Inflammation and Dysplasia in Patients With Barrett's Esophagus Eric M. Nelsen, Yujiro Kirihara,

Volume 123, Issue 5, Pages (November 2002)

Prateek Sharma, MD, Sachin Wani, MD, Amit Rastogi, MD

Volume 143, Issue 3, Pages e1 (September 2012)

Volume 120, Issue 4, Pages (March 2001)

Volume 125, Issue 5, Pages (November 2003)

Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis Marjolein Sikkema, Pieter.

Cytomegalovirus esophagitis in an immunocompetent host

Volume 122, Issue 7, Pages (June 2002)

Volume 117, Issue 1, Pages (July 1999)

Patients With Nondysplastic Barrett's Esophagus Have Low Risks for Developing Dysplasia or Esophageal Adenocarcinoma Sachin Wani, Gary Falk, Matthew.

Factors Associated With Progression of Barrett’s Esophagus: A Systematic Review and Meta-analysis Rajesh Krishnamoorthi, Siddharth Singh, Karthik Ragunathan,

Incidence of Progression of Persistent Nondysplastic Barrett’s Esophagus to Malignancy Yonne Peters, Judith Honing, Wietske Kievit, Christine Kestens,

Volume 130, Issue 4, Pages (April 2006)

AGA technical review on celiac sprue

Volume 122, Issue 4, Pages (April 2002)

Volume 124, Issue 4, Pages (April 2003)

Volume 122, Issue 4, Pages (April 2002)

Volume 152, Issue 1, Pages (January 2017)

Mechanisms of diarrhea in collagenous colitis

Volume 115, Issue 6, Pages (December 1998)

Volume 122, Issue 4, Pages (April 2002)

Janusz A. Jankowski, Dawn Provenzale, Paul Moayyedi Gastroenterology

Marcia Irene Canto, MD, MHS Gastrointestinal Endoscopy

Adherence to Biopsy Guidelines for Barrett's Esophagus Surveillance in the Community Setting in the United States Julian A. Abrams, Robert C. Kapel,

Prateek Sharma, Gary W. Falk, Allan P

Barrett’s Esophagus in Women: Demographic Features and Progression to High-Grade Dysplasia and Cancer Gary W. Falk, Prashanthi N. Thota, Joel E. Richter,

Low-grade dysplasia in Barrett’s esophagus

Volume 120, Issue 4, Pages (March 2001)

Volume 114, Issue 3, Pages (March 1998)

Comparison of narrow-band imaging, volumetric laser endomicroscopy, and pathologic findings in Barrett's esophagus Chikatoshi Katada, MD, Rish K. Pai,

Persistence of Nondysplastic Barrett’s Esophagus Is Not Protective Against Progression to Adenocarcinoma Rajesh Krishnamoorthi, Guilherme Piovezani Ramos,

Presentation transcript:

Volume 120, Issue 7, Pages 1630-1639 (June 2001) Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma Navtej S. Buttar, Kenneth K. Wang, Thomas J. Sebo, Darren M. Riehle, Krishnawatie K. Krishnadath, Lori S. Lutzke, Marlys A. Anderson, Tanya M. Petterson, Lawrence J. Burgart Gastroenterology Volume 120, Issue 7, Pages 1630-1639 (June 2001) DOI: 10.1053/gast.2001.25111 Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 1 Photomicrographs representing focal HGD. Arrows showing 2 crypts involved by HGD. The extent of HGD was defined as focal if cytologic and/or architectural changes of HGD were limited to a single focus of 5 or fewer crypts in 1 biopsy specimen of an entire set of surveillance biopsy specimens. Original magnification: 10X (A); 40X (B). Gastroenterology 2001 120, 1630-1639DOI: (10.1053/gast.2001.25111) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 2 Flow diagram outlining the patient exclusion criteria. Gastroenterology 2001 120, 1630-1639DOI: (10.1053/gast.2001.25111) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 3 The Kaplan–Meier curves comparing focal and diffuse HGD are shown. The percentage of patients that are cancer free at a given time period is shown on the y-axis, whereas the duration of follow-up from the index date in years is shown on the x-axis. Vertical bars indicate the 95% CI. Using the log-rank statistic, the P value is 0.0006. Gastroenterology 2001 120, 1630-1639DOI: (10.1053/gast.2001.25111) Copyright © 2001 American Gastroenterological Association Terms and Conditions